How should periventricular leukomalacia be managed in an adult?

Periventricular Leukomalacia in Adults: Management Approach

Periventricular leukomalacia (PVL) in adults is a historical finding from perinatal brain injury, not an active disease process requiring treatment—management focuses on identifying and addressing associated functional impairments rather than treating the white matter changes themselves.

Understanding PVL in the Adult Context

PVL represents permanent structural loss of white matter pathways from perinatal hypoxic-ischemic injury, typically occurring in premature infants 1. When identified in adults, this is a chronic, stable finding that reflects remote injury to the developing brain, not an ongoing pathological process 2.

Key Clinical Discriminators

The critical first step is distinguishing PVL from active white matter diseases that require intervention:

PVL characteristics on imaging:

• Periventricular white matter signal changes on T2/FLAIR sequences
• Posterior predominance (occipital > frontal)
• Stable appearance over time with no progression
• May show ventriculomegaly from chronic volume loss
• History of prematurity is essential 1, 3

What PVL is NOT:

• Progressive multifocal leukoencephalopathy (PML): shows progressive subcortical lesions with irregular borders, affects U-fibers, and demonstrates ongoing expansion 4
• Multiple sclerosis: acute lesions show contrast enhancement, periventricular flame-shaped lesions, and temporal evolution 4
• Metachromatic leukodystrophy: progressive demyelination with elevated CSF protein and ongoing neurological deterioration 5

Management Algorithm

Step 1: Confirm Diagnosis and Stability

Obtain detailed perinatal history:

• Gestational age at birth (especially <32 weeks)
• Birth complications (hypoxia, sepsis, intraventricular hemorrhage)
• Neonatal intensive care course 6

Review imaging:

• Compare current MRI with any prior studies to document stability
• If no prior imaging exists and clinical presentation is atypical, obtain follow-up MRI in 3-6 months to confirm non-progression 2

Step 2: Assess Functional Impact

Visual system evaluation (most common presentation in adults):

• Comprehensive ophthalmologic examination looking for:
  • Optic disc cupping (horizontal pattern, NOT vertical as in glaucoma)
  • Superior optic nerve thinning on OCT
  • Inferior homonymous visual field defects
  • Normal intraocular pressures 1
• Critical pitfall: PVL is frequently misdiagnosed as normal-tension glaucoma in adults with prematurity history 1

Neurological assessment:

• Motor function (spastic diplegia pattern most common)
• Cognitive function if concerns exist
• Seizure history 3

Step 3: Address Associated Impairments

Vision rehabilitation:

• Low vision services if visual field defects impact function
• Occupational therapy for adaptive strategies
• Do NOT treat as glaucoma—no role for IOP-lowering medications 1

Motor dysfunction:

• Physical therapy for spasticity management
• Orthopedic evaluation if musculoskeletal complications present
• Assistive devices as needed

Cognitive/behavioral support:

• Neuropsychological testing if functional concerns
• Appropriate educational or vocational accommodations

Step 4: Exclude Mimics Requiring Active Treatment

If clinical presentation suggests progression or atypical features 2:

Progressive neurological symptoms warrant investigation for:

• Inherited metabolic disorders (genetic testing, enzyme assays)
• Acquired demyelinating diseases (CSF analysis, contrast-enhanced MRI)
• Vascular disorders (MRA/CTA if indicated)

Red flags requiring further workup:

• New or worsening neurological deficits
• Imaging progression on serial studies
• Absence of prematurity history
• Atypical distribution of white matter changes

What NOT to Do

• Do not initiate neuroprotective therapies (erythropoietin, stem cells, melatonin)—these are investigational for acute perinatal injury prevention, not chronic adult PVL 7
• Do not perform lumbar puncture unless actively excluding PML or other infectious/inflammatory processes 4
• Do not treat with glaucoma medications based solely on optic disc cupping 1
• Do not pursue aggressive imaging surveillance—PVL is stable; repeat imaging only if clinical change occurs

Documentation and Counseling

Inform patients:

• PVL is a stable finding from birth complications, not a progressive disease
• Associated impairments (vision, motor) may benefit from rehabilitation
• No risk of transmission or worsening with normal activities
• Genetic counseling not indicated (acquired, not inherited condition)

For referring providers:

• Clarify that "periventricular white matter changes" in adults with prematurity history represent chronic PVL
• Distinguish from active demyelinating diseases requiring immunotherapy
• Emphasize functional assessment over repeated neuroimaging 2

The cornerstone of managing adult PVL is recognizing it as a historical marker rather than an active disease, avoiding misdiagnosis as conditions requiring treatment (especially glaucoma), and focusing rehabilitation efforts on functional impairments that impact quality of life 1, 3.